🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$4503.T
Astellas Pharma Inc.
FREE PREVIEW
📅 Next Earnings: Jul 30, 2026 ☀️ Open🌐 Website🏛️ Tokyo Stock Exchange📁 Healthcare🏭 Drug Manufacturers – General
AVG HISTORICAL GAP-0.12%
MAX GAP RECORD-1.84%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY0.7%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Astellas Pharma Inc. manufactures, markets, imports, and exports pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric cancer; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also provides VEOZAH, a treatment for vasomotor symptoms due to menopause; IZERVAY, a treatment… Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL